Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / April / Turning Proteins into DNA for UltraSensitive Sequencing
Omics Genomics & DNA Analysis News and Research Mass Spectrometry

Turning Proteins into DNA for Ultra-Sensitive Sequencing

Stanford researchers repurpose DNA sequencing technology to read proteins at single-molecule resolution, complementing – and potentially surpassing – mass spectrometry

04/02/2026 1 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Report: Turning Proteins into DNA for Ultra-Sensitive Sequencing

Overview

Stanford University bioengineers have developed a method called 'reverse translation' that converts protein sequences into DNA, allowing for ultra-sensitive sequencing with single-molecule detection. This technique shows promise in detecting rare peptides and could enhance our understanding of cellular heterogeneity and therapeutic responses.

Background

The ability to accurately sequence proteins is crucial for advancing personalized medicine and understanding disease mechanisms. Traditional methods like mass spectrometry have limitations in sensitivity and detection of low-abundance proteins. The new reverse translation approach could significantly improve the detection of proteins and their modifications, which is essential for developing effective therapies.

Data Highlights

The reverse translation method achieved ~98% accuracy in validation experiments and can detect peptides at ratios as low as one in a million.

Key Findings

  • The reverse translation technique allows for the conversion of protein sequences into DNA sequences.
  • This method can achieve single-molecule sensitivity with minimal sample requirements.
  • It can potentially detect up to 1,000 times more proteins compared to traditional mass spectrometry.
  • The technique is built on principles from Edman degradation and antibody-based detection.
  • Researchers aim to develop a push-button instrument for comprehensive single-cell proteome mapping.

Clinical Implications

The reverse translation method could revolutionize protein analysis by enabling high-throughput sequencing of proteins, which may lead to better understanding of disease mechanisms and therapeutic responses. Clinicians may need to adapt to new workflows that incorporate this technology for enhanced diagnostic capabilities.

Conclusion

Highlight the need for further research and potential timelines for integration.

Related Resources & Content

  1. Stanford University, Nature Biotechnology, 2026 -- Single-molecule peptide sequencing through reverse translation of peptides into DNA
  2. Archives of Toxicology, 2021 -- Nuclease Targeting Single-Strands Improves Precision in Error-Corrected Sequencing and Enhances Detection of Rare Mutations
  3. the medicine maker, 2026 -- Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
  4. the pathologist, 2026 -- Unlocking Hidden RNA Signals
  5. Archives of Toxicology — Comprehensive Analysis of Somatic Mutations Using Hawk-Seq™ Identifies Mutation Patterns Linked to Chemical Agents
  6. Single-molecule peptide sequencing through reverse translation of peptides into DNA | Nature Biotechnology
  7. Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank | Scientific Reports
  8. Multi-cancer Detection (MCD) Tests | American Cancer Society

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.